These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19430549)

  • 1. Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study.
    Iwamoto J; Matsumoto H; Tadeda T; Sato Y; Yeh JK
    Yonsei Med J; 2009 Apr; 50(2):189-94. PubMed ID: 19430549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
    Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
    Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
    Iwamoto J; Takeda T; Sato Y; Yeh JK
    Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
    Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
    Exp Anim; 2006 Jul; 55(4):349-55. PubMed ID: 16880682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S
    J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study.
    Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2007 Jun; 53(3):191-7. PubMed ID: 17874822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations.
    Willey JS; Livingston EW; Robbins ME; Bourland JD; Tirado-Lee L; Smith-Sielicki H; Bateman TA
    Bone; 2010 Jan; 46(1):101-11. PubMed ID: 19747571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin K2 on cortical and cancellous bone mass, cortical osteocyte and lacunar system, and porosity in sciatic neurectomized rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Yeh JK
    Calcif Tissue Int; 2010 Sep; 87(3):254-62. PubMed ID: 20556371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization.
    Yao W; Cheng Z; Pham A; Busse C; Zimmermann EA; Ritchie RO; Lane NE
    Arthritis Rheum; 2008 Nov; 58(11):3485-97. PubMed ID: 18975341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.
    Ito M; Nakayama K; Konaka A; Sakata K; Ikeda K; Maruyama T
    Bone; 2006 Sep; 39(3):453-9. PubMed ID: 16581323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of bisphosphonate on trabecular microstructure].
    Ito M
    Nihon Rinsho; 2003 Feb; 61(2):213-8. PubMed ID: 12638210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse.
    Yang Li C; Majeska RJ; Laudier DM; Mann R; Schaffler MB
    Bone; 2005 Sep; 37(3):287-95. PubMed ID: 16006205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal effects of constant and terminated use of risedronate on cortical bone in ovariectomized rats.
    Li QN; Liang NC; Huang LF; Wu T; Hu B; Mo LE
    J Bone Miner Metab; 1999; 17(1):18-22. PubMed ID: 10084397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.